Linder M M, Voigt H G
Med Klin. 1975 May 9;70(19):847-51.
The effectiveness of a postoperative thyroid-hormone therapy in preventing a goiter-recidiv was investigated two years after goiter-resection. Of 3381 patients with goiter, who were operated on in the years 1964 to 1973 in the Surgical Department of the Krankenhaus Nordwest in Frankfurt/Main, Germany, 129 patients who were operated on in the first six months of 1969, were questioned and examined in a follow-up study. A rezidiv-goiter was found in 4, 6 p.c. of patients. If only palpable recidiv-goiters are taken into consideration 2, 3 p.c.), patients without postoperative thyroid-hormone therapy developed a recidiv goiter twice as often as patients with thyroid-hormone therapy.
在甲状腺肿切除术后两年,对术后甲状腺激素疗法预防甲状腺肿复发的有效性进行了调查。1964年至1973年期间,在德国美因河畔法兰克福西北医院外科接受手术的3381例甲状腺肿患者中,对1969年上半年接受手术的129例患者进行了随访研究并询问和检查。发现4.6%的患者出现复发性甲状腺肿。如果仅考虑可触及的复发性甲状腺肿(2.3%),未接受术后甲状腺激素治疗的患者发生复发性甲状腺肿的频率是接受甲状腺激素治疗患者的两倍。